Search academic texts

Information × Registration Number 0307U007699, 0107U009847 , R & D reports Title PGT 305: Paclitaxel Poliglumex (CT-2103) vs Paclitaxel for the Treatment of Women with Chemotherapy-Naive Advanced Non-Small Cell Lung Cancer (NSCLC) who are Performance Status 2. popup.stage_title Проведення циклів лікування, відслідковування виживаності пацієнтів. Статистична обробка результатів дослідження. Head Hotko Evgen Stepanovych, Registration Date 05-11-2007 Organization Uzhgorod National University popup.description2 By results of the work (analysis of a survival rate, the time before progression of disease) is demonstrated, that the investigational drug (СТ-2103) is rather worst than paclitaxel at treatment of females with IIIB - IV by stages of a NSCLC. However the toxic developments at application СТ-2103 did not exceed neither on frequency, not on a degree of manifestation those at application of paclitaxel.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close